Albany, US – DelveInsight launched a new report on Acute Heart failure Market Insights, Epidemiology and Market Forecast-2028
DelveInsight’s “Acute Heart failure (AHF) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acute Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The key fact of the report:
“The patients are predominantly male with a mean age of >70 years, which is consistent with the epidemiology of ischemic heart disease. The in-hospital mortality ranges from four to seven per cent, with a median length of stay between 4 and 11 days in the disease.”
Key benefits of the report:
1. Acute Heart failure market report covers a descriptive overview and comprehensive insight of the Acute Heart failure epidemiology and Acute Heart failure market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)2. Acute Heart failure market report provides insights into the current and emerging therapies.3. Acute Heart failure market report provides a global historical and forecasted market covering drug outreach in 7 MM.4. Acute Heart failure market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acute Heart failure market.
Request for sample page: https://www.delveinsight.com/sample-request/acute-heart-failure-ahf-market
Acute heart failure can result due to a number of causes, such as allergic reaction, a blood clot in a lung, a complication of cardiopulmonary bypass surgery, heart attack or myocardial infarction, infection, severely irregular heartbeat, etc.
Acute heart failure (AHF), also known as an acute decompensated heart failure or cardiac failure, is not a single disease entity, but rather a syndrome of the worsening signs and symptoms reflecting an inability of the heart to pump blood at a rate equal to the needs of the body at normal filling pressure.
The key players in Acute Heart failure market are:1. Boehringer Ingelheim2. NovartisAnd many others
The launch of the emerging therapies is expected to significantly impact the Acute Heart failure treatment scenario in the upcoming years:-Drugs covered1. Empagliflozin2. Sacubitril/valsartanAnd many others
Request a free sample report @https://www.delveinsight.com/sample-request/acute-heart-failure-ahf-market
Table of contents
1. Report Introduction2. Acute Heart Failure Market Overview at a Glance3. Acute Heart Failure Disease Background and Overview4. Acute Heart Failure Epidemiology and Patient Population5. Acute Heart Failure Country-Wise Epidemiology6. United States7. EU–5 Countries7.1. Assumptions and Rationale7.2. Germany7.3. France7.4. Italy7.5. Spain7.6. United Kingdom7.7. Japan8. Acute Heart Failure Treatments and Medical Practices9. Acute Heart Failure Emerging Therapies10. Key Cross Competition10.1. Empagliflozin: Boehringer Ingelheim10.2. Sacubitril/valsartan: Novartis11. Acute Heart Failure Market Size12. 7MM Acute Heart Failure Country-Wise Market Analysis13. United States Market Size14. EU5 Market Size14.1.Germany Market Size14.2. France Market Size14.3.United Kingdom Market Size14.4. Spain Market Size14.5. Italy Market Size15. Japan Market Size16. Acute Heart Failure Report Methodology17. DelveInsight Capabilities18. Disclaimer19. About DelveInsight
Related Reports:
Acute Heart failure (AHF) – Epidemiology Forecast to 2030
Acute Heart failure (AHF) Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NEVADA 89107Country: United StatesWebsite: https://www.delveinsight.com/